Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...
Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented today as late-breaking ...
ATLANTA, GA (May 20, 2022) – Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented ...
Lipomas can occur in the heart, including in the visceral and parietal pericardium. Parietal pericardial lipomas are often clinically mistaken for pericardial cysts. Multiple myocardial lipomas have ...
NEW ORLEANS, LA—A novel transcatheter intracardiac shunt device appears to provide sustained clinical benefit at 1 year in heart failure patients with preserved or only mildly reduced ejection ...
FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial. In its premarket approval application for the ...
ANAHEIM, CA—An intracardiac shunt device safely unloads pressure within the left atrium among patients with heart failure and preserved or mildly impaired left ventricular function, according to the ...
For well-treated patients refractory to standard medications, the Ventura interatrial shunt was no better than sham in terms of primary effectiveness over nearly 2 years, defined by a hierarchical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback